Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
17
Number of overlapping holdings
20.0%
% of SBIO's 89 holdings also in BBP
27.9%
% of BBP's 65 holdings also in SBIO
Overlap by Weight
Sector Drift (SBIO minus BBP)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in SBIO |
Weight in BBP |
Overlap | |
|---|---|---|---|---|
 |
TARSUS PHARMACEUTICALS, INC. | 1.7% | 1.8% | 1.7% |
 |
ZAI LAB LTD. UNSPONSORED ADR | 2.3% | 1.6% | 1.6% |
|
RHYTHM PHARMACEUTICALS, INC. | 2.9% | 1.6% | 1.6% |
|
ACADIA PHARMACEUTICALS INC | 2.4% | 1.6% | 1.6% |
|
MIRUM PHARMACEUTICALS, INC. | 1.6% | 1.6% | 1.6% |
Position Highlights (Non-Overlapping Exposures)
SBIO Overweight Relative to BBP
 |
ALKERMES PLC | 3.8% |
|
CRINETICS PHARMACEUTICALS INC | 3.1% |
|
AVIDITY BIOSCIENCES INC | 2.9% |
 |
MERUS N.V. | 2.5% |
|
VERICEL CORPORATION | 2.4% |
 |
MOONLAKE IMMUNOTHERAPEUTICS CLASS A | 2.4% |
|
DENALI THERAPEUTICS INC. | 2.3% |
|
VERA THERAPEUTICS, INC. CLASS A | 1.9% |
|
EDGEWISE THERAPEUTICS, INC. | 1.9% |
|
PROTAGONIST THERAPEUTICS, INC. | 1.8% |
SBIO Underweight Relative to BBP
|
NEUROCRINE BIOSCIENCES INC | -1.8% |
|
HARMONY BIOSCIENCES HOLDINGS, INC. | -1.8% |
|
TG THERAPEUTICS INC | -1.7% |
|
ASCENDIS PHARMA A/S | -1.7% |
|
MADRIGAL PHARMACEUTICALS, INC. | -1.7% |
|
GILEAD SCIENCES INC | -1.7% |
|
PHATHOM PHARMACEUTICALS, INC. | -1.7% |
|
INTRA-CELLULAR THERAPIES INC | -1.7% |
|
BRIDGEBIO PHARMA, INC. | -1.6% |
|
BEIGENE LTD. SPONSORED ADR | -1.6% |